Manchester Financial Inc Seres Therapeutics, Inc. Transaction History

Manchester Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$18.46 - $24.36 $18,460 - $24,360	-1,000 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$2.99 - $4.42 $2,990 - $4,420	1,000 New	1,000 $3,000
Q3 2019 Oct 09, 2019	SELL	$2.29 - $4.16 $2,290 - $4,160	-1,000 Closed	0 $0
Q2 2019 Jul 23, 2019	BUY	$2.28 - $7.35 $2,280 - $7,350	1,000 New	1,000 $3,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $86.9M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Manchester Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Manchester Financial Inc with notifications on news.